The state of New Jersey currently has 1 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Recruiting
This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may lead to scarring (cirrhosis). PBC may also be associated with multiple symptoms including pruritus (itching) and fatigue. Many patients with PBC may require liver transplant or may die if the disease progresses and a liver... Read More
Gender:
ALL
Ages:
All
Trial Updated:
08/14/2025
Locations: Virtua Center for Liver Disease - Cherry Hill, Cherry Hill, New Jersey
Conditions: Primary Biliary Cholangitis